Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Product sales, net	$ 2,909,966	$ 1,648,368	$ 5,507,564	$ 4,349,270
Cost of products sold	1,019,907	967,720	1,728,882	1,986,196
Gross profit	1,890,059	680,648	3,778,682	2,363,074
Selling, general and administrative expenses	3,937,281	3,282,322	7,011,012	6,397,948
Research and development expenses	213,647	266,560	353,994	731,027
Depreciation and amortization expense	16,681	16,645	33,902	33,460
Total operating expenses	4,167,609	3,565,527	7,398,908	7,162,435
Loss from operations	(2,277,550)	(2,884,879)	(3,620,226)	(4,799,361)
Interest income (expense)	48,722	3,550	72,067	(1,193)
Loss before provision for income taxes	(2,228,828)	(2,881,329)	(3,548,159)	(4,800,554)
Net loss	(2,228,828)	(2,881,329)	(3,548,159)	(4,800,554)
Net loss attributable to noncontrolling interests	(12,511)	(22,848)	(24,176)	(40,350)
Net loss attributable to Milestone Scientific Inc.	$ (2,216,317)	$ (2,858,481)	$ (3,523,983)	$ (4,760,204)
Net loss per share applicable to common stockholders—
Basic and Diluted (in dollars per share)	$ (0.03)	$ (0.04)	$ (0.05)	$ (0.07)
Weighted average shares outstanding and to be issued—
Basic and Diluted (in shares)	72,333,656	70,356,796	72,048,223	70,585,590